A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.

Autor: Mato Prado, Mireia^1,2 (AUTHOR), Puik, Jisce R.^3,4 (AUTHOR), Castellano, Leandro^1,5 (AUTHOR), López-Jiménez, Elena¹ (AUTHOR), Liu, Daniel S. K.¹ (AUTHOR), Meijer, Laura L.^3,4 (AUTHOR), Le Large, Tessa Y. S.^3,4 (AUTHOR), Rees, Eleanor¹ (AUTHOR), Funel, Niccola⁶ (AUTHOR), Sivakumar, Shivan⁷ (AUTHOR), Pereira, Stephen P.⁸ (AUTHOR), Kazemier, Geert^3,4 (AUTHOR), Zonderhuis, Babs M.^3,4 (AUTHOR), Erdmann, Joris I.^3,4 (AUTHOR), Swijnenburg, Rutger-Jan^3,4 (AUTHOR), Frilling, Andrea⁹ (AUTHOR), Jiao, Long R.⁹ (AUTHOR), Stebbing, Justin^1,10 (AUTHOR), Giovannetti, Elisa^4,11 (AUTHOR) elisa.giovannetti@gmail.com, Krell, Jonathan¹ (AUTHOR) j.krell@imperial.ac.uk

Publikováno v: Experimental Hematology & Oncology. 12/1/2023, Vol. 12 Issue 1, p1-7. 7p.

Morbidity and mortality of elderly patients with pancreaticobiliary disease according to age and comprehensive geriatric assessment: A prospective observational study

Autor: Parrales-Mora, Mauricio, Cremades, Manel, Parés, David, García, Rebeca D., Pardo Aranda, Fernando, Zárate Pinedo, Alba, Navinés López, Jordi, Espin Alvarez, Francisco, Julian-Ibanez, Joan-Francesc, Cugat Andorra, Esteban

Publikováno v: In Gastroenterología y Hepatología (English Edition) May 2024 47(5):439-447

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease

Autor: Mireia Mato Prado, Jisce R. Puik, Leandro Castellano, Elena López-Jiménez, Daniel S. K. Liu, Laura L. Meijer, Tessa Y. S. Le Large, Eleanor Rees, Niccola Funel, Shivan Sivakumar, Stephen P. Pereira, Geert Kazemier, Babs M. Zonderhuis, Joris I. Erdmann, Rutger-Jan Swijnenburg, Andrea Frilling, Long R. Jiao, Justin Stebbing, Elisa Giovannetti, Jonathan Krell, Adam E. Frampton

Publikováno v: Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-7 (2023)

Abstract Differentiating between pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA) is crucial for the appropriate course of treatment, especially with advancements in the role of neoadjuvant chemotherapies for PDAC, compared to CCA

Externí odkaz: https://doaj.org/article/4aa06997730e41ed9d09b56507c2f5e6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Concise Commentary: Does COVID-19 Worsen Severe Pancreaticobiliary Disease?

Autor: Kim M; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Saint Louis University, St. Louis, MO, USA. Marina.kim@health.slu.edu.

Publikováno v: Digestive diseases and sciences [Dig Dis Sci] 2024 Aug; Vol. 69 (8), pp. 3019-3020. Date of Electronic Publication: 2024 Jul 18.